Journal List > J Korean Ophthalmol Soc > v.50(12) > 1008461

Chun and Kim: Strabismus Surgery in Myasthenia Gravis

Abstract

Purpose

To report the results of strabismus surgery in five patients diagnosed with myasthenia gravis with strabismus.

Case summary

The authors retrospectively analyzed the effect and timing of surgery for patients who developed strabismus after being diagnosed for myasthenia gravis. Cases 1 and 2 were female myasthenia gravis patients, eight and 45 years of age, who underwent surgery after symptoms developed for correction of exotropia at 33 months and ten years after diagnosis, respectively. Case 3 was a 33-year-old male hyperthyroidism patient who had an exotropia operation six years after his strabismus diagnosis. Cases 4 and 5 were a 22– year-old female and a 50-year-old male patient, who underwent surgery for correction of left hypotropia at 14 months and ten months after diagnosis, respectively. Eventually, a total of three cases of horizontal deviation and two cases of vertical deviation had successful outcomes resulting within ten prism diopters. The patients in cases 4 and 5, both of whom had vertical deviations, experienced a short wait time from the date of symptom presentation until they were able to receive surgery. In particular, case 5 developed left hypertropia two months prior to surgery and the strabismus angle increased until six months prior to surgery. However, the hypertropia stabilized afterwards and the patient finally obtained orthophoria after a left inferior rectus advancement operation.

Conclusions

In patients diagnosed with myasthenia gravis and a large angle strabismus, a longer follow-up period from diagnosis to operation is necessary for a successful postoperative outcome and stable strabismus angle.

References

1. Vincent A, Willcox N, Hill M, et al. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol Rev. 1998; 164:157–68.
crossref
2. Heckmann JM, Owen EP, Little F. Myasthenia gravis in South Africans: racial differences in clinical manifestations. Neuromuscul Disord. 2007; 17:929–34.
crossref
3. Oöpik M, Puksa L, Luus S-M, et al. Clinical and laboratory- reconfirmed myasthenia gravis: a population-based study. Eur J Neurol. 2008; 15:246–52.
4. Mantegazza R, Baggi F, Antozzi C, et al. Myasthenia gravis (MG): epidemiological data and prognostic factors. Ann N Y Acad Sci. 2003; 998:413–23.
crossref
5. Zhang X, Yang M, Xu J, et al. Clinical and serological study of myasthenia gravis in HuBei Province, China. J Neurol Neurosurg Psychiatry. 2007; 78:386–90.
crossref
6. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology. Incidence of myasthenia gravis in the Emilia- Romagna region: a prospective multicenter study. Neurology. 1998; 51:255–8.
7. Morris OC, O'Day J. Strabismus surgery in the management of diplopia caused by myasthenia gravis. Br J Ophthalmol. 2004; 88:832.
8. Davidson JL, Rosenbaum AL, McCall LC. Strabismus surgery in patients with myasthenia. J Pediatr Ophthalmol Strabismus. 1993; 30:292–5.
crossref
9. Bentley CR, Dawson E, Lee JP. Active management of patients with ocular manifestations of myasthenia gravis. Eye. 2001; 15:18–22.
10. Mein J, Harcourt B. Diagnosis and management of ocular motility disorders. Oxford: Blackwell;1986. p. 324–6.
11. Glaser JS. Clinical ophthalmology. Philadelphia: Lipincott;1988. p. 31–7.
12. Miller NR. Myopathies and disorders of neuromuscular transmission. Walsh and Hoyt's clinical neuro-ophthalmology. 4th ed.St Louis: Mosby;1987. p. 859–60.
13. Acheson JF, Elston JS, Lee JP, Fells P. Extraocular muscle surgery in myasthenia gravis. Br J Ophthalmol. 1991; 75:232–5.
crossref
14. Bartley GB, Fatourechi V, Kadrmas EF, et al. Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996; 121:284–90.
crossref
15. Brodsky MC, Pollock SC, Buckley EG. Neural misdirection in congenital ocular fibrosis syndrome: implications and pathogenesis. J Pediatr Ophthalmol Strabismus. 1989; 26:159–61.
crossref
16. Christensen PB, Jensen TS, Tsiropoulos I, et al. Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurol Scand. 1995; 91:192–5.
crossref

Figure 1.
Preoperative (top) and postoperative (bottom) photographs of patient 1. The patient showed 10ΔX 4ΔRH at 7 months after the surgery.
jkos-50-1902f1.tif
Figure 2.
Preoperative (top) and postoperative (bottom) photographs of patient 2. Note large angle exotropia and adduction deficit in both eyes. The patient showed 2ΔX at 1 month after the surgery.
jkos-50-1902f2.tif
Figure 3.
Preoperative (top) and postoperative (bottom) photographs of case 3. associated with thyroid-related orbitopathy. Note the pattern like divergence fixus.
jkos-50-1902f3.tif
Figure 4.
Preoperative (top) and postoperative (bottom) photographs of patient 4. The patient showed orthotropia 3 months after the surgery (bottom).
jkos-50-1902f4.tif
Figure 5.
Preoperative (a), postoperative (b) and 2nd postoperative (c) photographs of patient 5. The patient showed 12ΔLHT at 2 months after 1st surgery and orthotropia at 1 month after the 2nd surgery in primary gaze.
jkos-50-1902f5.tif
Figure 6.
The patient 6 showed no definite extorsion in both eyes at 2 months after 1 st surgery.
jkos-50-1902f6.tif
Table 1.
Patient profiles
case Sex/age Duration (Mon) Preop deviation BCVA (OD/OS) OP name Postop deviation Ptosis
1 F/8 33 30△ X(T)* 6△ RH 1.0/0.9 RLR rec. 7 mm, LLR rec. 7 mm 10△ X 4△ RH +
2 F/45 180 60△ RXT 5△ RH 1.0/1.0 LROU rec. 8.5 mm/8.5 mm 6△ X +
          RMR res. 5 mm, LMR res. 3 mm    
3 M/33 124 60△ LXT 0.6/0.6 LROU rec. 9 mm/9 mm ortho
4 F/22 14 30△ LHOTΠ 1.0/0.7 LIR rec. 4 mm, RSR rec. 6 mm ortho +
5 M/50 10 30△ RHT§ 10△ X# 1.0/1.0 1st: RSR rec. 6 mm, LIR rec. 4 mm 18△ LHT
      18△ LHT   2nd: LIR adv. 4 mm ortho  

* X(T)=intermittent exotropia

XT=constant exotropia

H=hyperphoria

§ HT=hypertropia

Π HOT=hypotropia

# X=exophoria.

TOOLS
Similar articles